impact of sglt2 inhibitor on all-cause mortality among patients with type 2 diabetes with and without ckd

Abdullah Almuhaiteeb, Mohamed Abu-Farha, Jehad Abubaker, Hamad Ali, Fahd Al-Mulla

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	849
Number of pages	1
Journal	Journal of the American Society of Nephrology
Volume	34
Issue number	11
State	Published - 2023

Funding Agency

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9b96ff35aa844457b8fddfacddede344,

title = "impact of sglt2 inhibitor on all-cause mortality among patients with type 2 diabetes with and without ckd",

author = "Abdullah Almuhaiteeb and Mohamed Abu-Farha and Jehad Abubaker and Hamad Ali and Fahd Al-Mulla",

year = "2023",

language = "American English",

volume = "34",

pages = "849",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

number = "11",

}

TY - JOUR

T1 - impact of sglt2 inhibitor on all-cause mortality among patients with type 2 diabetes with and without ckd

AU - Almuhaiteeb, Abdullah

AU - Abu-Farha, Mohamed

AU - Abubaker, Jehad

AU - Ali, Hamad

AU - Al-Mulla, Fahd

PY - 2023

Y1 - 2023

M3 - Article

SN - 1046-6673

VL - 34

SP - 849

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 11

ER -